Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Robert Hancock and Host Defense Peptides: What's in a Name?

ACS infectious diseases·2026

Same author

Protocol for the generation of a human-derived nasal epithelial model and induction of tissue-resident memory-like T cells in a co-culture system.

STAR protocols·2026

Same author

A Novel Air-Liquid Interface Exposure System for Continuous Gas Exposure of Airway Epithelial Cells: Exposure of NO<sub>2</sub> With Viral Co-Challenge.

Journal of applied toxicology : JAT·2026

Same author

Beyond a metabolite: lactate and lactylation in lung diseases.

Respiratory research·2026

Same author

Prior Exposure of Airway Epithelial Cells to Mycobacteria Reduces Subsequent <italic>Mycobacterium tuberculosis</italic> Infection and Resulting Inflammation.

Journal of innate immunity·2025

Same author

Extracellular Matrix and Endothelial Activation Markers in the Bronchial and Pulmonary Arteries in COPD.

The clinical respiratory journal·2025

Same journal

Population Health Management in Chronic Obstructive Pulmonary Disease: An Official American Thoracic Society Workshop Report.

Annals of the American Thoracic Society·2026

Same journal

Cell Lysis Pneumopathy in Patients with Hyperleukocytic Acute Myeloid Leukemia.

Annals of the American Thoracic Society·2026

Same journal

Morphologic evaluation in fibrotic hypersensitivity pneumonitis: the era of quantitative CT is upon us.

Annals of the American Thoracic Society·2026

Same journal

"From Guidelines to Practice: The PuSHCon Health-Coach Model for COPD and Asthma".

Annals of the American Thoracic Society·2026

Same journal

Fine particulate matter exposure and long-term lung-function trajectory in adults with cystic fibrosis.

Annals of the American Thoracic Society·2026

Same journal

Lung Health Lessons Learned Abroad Are Critical To Understanding Lung Health at Home.

Annals of the American Thoracic Society·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

Altered macrophage function in chronic obstructive pulmonary disease.

Pieter S Hiemstra¹

¹1 Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands.

Annals of the American Thoracic Society

|December 10, 2013

Summary

This summary is machine-generated.

Macrophages in chronic obstructive pulmonary disease (COPD) are increased and impair pathogen clearance. While their function can be restored in vitro, a COPD-specific subset may exist, requiring further research to link dysfunction to disease phenotypes.

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

Related Experiment Videos

Last Updated: May 5, 2026

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

Area of Science:

Pulmonary Medicine
Immunology
Cell Biology

Background:

Macrophages are elevated in chronic obstructive pulmonary disease (COPD) and linked to disease severity.
These immune cells contribute to lung tissue injury via mediators like matrix metalloprotease-12.
Macrophage dysfunction in COPD includes impaired clearance of pathogens and apoptotic cells.

Purpose of the Study:

To investigate the altered function and phenotype of macrophages in COPD.
To understand the heterogeneity of macrophage populations in COPD.
To explore potential COPD-specific macrophage subsets.

Main Methods:

Review of studies on macrophage function and phenotyping in COPD.
Analysis of macrophage polarization markers (M1, M2, M2-like).
Consideration of in vitro studies demonstrating partial restoration of macrophage function.

Main Results:

Macrophages in COPD exhibit impaired phagocytic capacity.
Evidence suggests a potential intermediate or COPD-specific macrophage phenotype, not a clear M1 or M2 predominance.
In vitro studies indicate that macrophage function can be partially restored.

Conclusions:

Macrophage dysfunction is a key feature of COPD, contributing to disease pathology.
Further research is necessary to characterize the proposed COPD-specific macrophage subset.
Linking specific macrophage phenotypes and dysfunction to distinct COPD phenotypes is a critical future direction.